Fig. 1From: Carbon ion therapy (C12) for high-grade malignant salivary gland tumors (MSGTs) of the head and neck: do non-ACCs profit from dose escalation?C12 treatment plan of a patient with mucoepidermoid carcinoma of the paranasal sinus undergoing combined IMRT plus C12 boost. C12 plan based on 2 beams, intensity-controlled C12 therapy (ICCT) to 24 GyE in 3 GyE per fraction. a and b: axial; c: coronal distributionBack to article page